SynthesisPloS one2014

The prognostic value of excision repair cross-complementation group 1 (ERCC1) in patients with small cell lung cancer (SCLC) receiving platinum-based chemotherapy: evidence from meta-analysis.

Yanlong Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.